GR EN
Home About Chiesi     Our history     Mission and Values     Οικονομικές Καταστάσεις     Disclosure     Annual and Sustainability Report     B Corp Pharmacovigilance Therapeutic areas      Respiratory      Neonatology      Rare Diseases Contacts Product Portfolio     Respiratory     Neonatology     Special Care     Medical Devices     Other medicinal products Research & Development Join Chiesi     New openings Sustainability     Our approach     We ACT - Sustainability Manifesto     Products and patients     Processes     Global Value Chain     Corporate Citizenship     Chiesi Foundation     Sustainability Report Media Live events & Webcasts
  • Home
  • |
  • Pharmacovigilance
  • |
  • Contacts
  • |
  • SpeakUp&BeHeard
  • |
  • Chiesi Group
  • GR
  • EN
Welcome to Chiesi
Greece
Enter at least 3 characters
  • About Chiesi
    • Our history
    • Mission and Values
    • Οικονομικές Καταστάσεις
    • Disclosure
    • Annual and Sustainability Report
    • B Corp
  • Therapeutic areas
    • Respiratory
    • Neonatology
    • Rare Diseases
  • Product Portfolio
    • Respiratory
    • Neonatology
    • Special Care
    • Medical Devices
      • Products
      • Materiovigilance
    • Other medicinal products
  • Research & Development
  • Join Chiesi
    • New openings
  • Sustainability
    • Our approach
    • We ACT - Sustainability Manifesto
    • Products and patients
    • Processes
      • Environment
      • Our people
    • Global Value Chain
      • Supply Chain Sustainability
    • Corporate Citizenship
      • Ethics and Transparency
      • Communities
      • European and International Agenda
    • Chiesi Foundation
    • Sustainability Report
  • Media
Home page > Therapeutic area

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Respiratory

Chiesi Farmaceutici is fully committed to the care and improvement of the quality of life of people suffering from respiratory diseases including...

Neonatology

Normally, delivery takes place between the 37th and the 42nd week of gestation.

Rare Diseases

Chiesi has been focused on the centrality of the patient for decades. In 2019, Chiesi created a unit specifically dedicated to the development and...
© 2022 Chiesi Hellas Α.Ε.Β.Ε.
Geroulanou Sq. & 1 Renou Poggi 17455 Alimos, Athens
Phone: 210 61 79 786
Fax: 210 61 79 786
Email: chiesihellas@chiesi.com
  • Sitemap
  • Admin
  • Cookies
  • Terms of use
  • SpeakUp&BeHeard
  • Privacy
  • Credits
  • Κατευθυντήριες οδηγίες Facebook
CHIESI ON THE WEB
follow us on:

CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
France
Chiesi S.A.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.